Nobel Biocare expands CAD/CAM business with $32 million deal
Nobel Biocare has signed an agreement to purchase 100% of BioCad Medical, a developer of computer-aided design (CAD) software for prosthetics, for 26 million euros ($32 million U.S.), the company announced. The purchase includes all rights to BioCad’s trademark, brand names, strong R&D network, and a facility in Quebec City, Canada. Nobel Biocare said it will retain all 40 BioCad employees. Nobel Biocare also announced the signing of an exclusive


